Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Central Nervous System Diseases × Saline Solution × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 10 Supratentorial Neoplasms 2 Spinal Cord Neoplasms 1 Seizures 1 Pain, Postoperative 1 Neuroinflammatory Diseases 1 Neurofibromatosis 1 1 Neurocognitive Disorders 1 Neoplasms 1 Meningioma 1 Hypoxia 1 Hemorrhage 1 Glioma 1 Glioblastoma 1 Epilepsy 1 Emergence Delirium 1 Delirium 1 Central Nervous System Vascular Malformations 1 Central Nervous System Diseases 1 Arteriovenous Malformations 1 Aneurysm 1

Interventions

Temozolomide 3 gadobenic acid 2 XENP 1595 2 Trastuzumab 2 Sodium Chloride 2 Dexmedetomidine 2 Cancer Vaccines 2 Adjuvants, Immunologic 2 veliparib 1 tucatinib 1 tipifarnib 1 sagopilone 1 pembrolizumab 1 glutathione pegylated liposomal doxorubicin 1 gadoteridol 1 elacestrant 1 abemaciclib 1 Tissue Banks 1 Saline Solution 1 Rituximab 1 Radiotherapy 1 Radiation 1 RAD1901 1 Dasatinib 1 Craniotomy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04399343 2021-01-28

DEPOD

Capital Medical University

Phase 4 Unknown

Central Nervous System Diseases, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon ⚡